ALXN

2 members of Congress have disclosed 9 trades in ALXN (ALXN) via STOCK Act filings. The most recent disclosure was a sale by Gilbert Cisneros on 22 December 2020. The most active traders have been Gilbert Cisneros (8) and Lois Frankel (1). Aggregate disclosed activity totals roughly $32K in purchases and $123.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ALXN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ALXN

5 transactions
Compliance: 100%
Gilbert Cisneros22 Dec 202011 Jan 2021SaleStock$15,001 - $50,000N/A
Gilbert Cisneros21 Dec 202011 Jan 2021SaleStock$50,001 - $100,000N/A
Gilbert Cisneros14 Jul 202019 Aug 2020PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros13 Jul 202019 Aug 2020PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros24 Feb 202010 Mar 2020PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

No overview data available for this stock

Earnings

Recent Quarters

Q2 202129 Jul
EPS-
Q1 202130 Apr
EPS$3.52
Beat 11.4%
Q4 20204 Feb
EPS$2.96
Beat 15.6%
Q3 202029 Oct
EPS$3.24
Beat 24.6%
Q2 202030 Jul
EPS$3.11
Beat 20.1%
Q1 20206 May
EPS$3.22
Beat 18.8%
Q4 201930 Jan
EPS$2.71
Beat 4.2%
Q3 201923 Oct
EPS$2.79
Beat 13.0%
Q2 201924 Jul
EPS$2.64
Beat 12.8%
Q1 201925 Apr
EPS$2.39
Beat 9.1%
Q4 20184 Feb
EPS$2.14
Beat 17.6%
Q3 201824 Oct
EPS$2.02
Beat 16.1%
Q2 201826 Jul
EPS$2.07
Beat 21.8%
Q1 201826 Apr
EPS$1.68
Beat 12.0%
Q4 20178 Feb
EPS$1.48
Beat 16.5%
Q3 201726 Oct
EPS$1.44
Beat 9.1%
Q2 201727 Jul
EPS$1.56
Beat 23.8%
Q1 201727 Apr
EPS$1.38
Beat 12.2%
Q4 201616 Feb
EPS$1.26
Beat 0.8%
Q3 201627 Oct
EPS$1.23
Beat 5.1%
Q2 201628 Jul
EPS$1.13
Miss 3.4%
Q1 201628 Apr
EPS$1.11
Miss 2.6%
Q4 20153 Feb
EPS$1.13
Beat 2.7%
Q3 201529 Oct
EPS$1.16
Beat 14.8%
Q2 201530 Jul
EPS$1.44
Beat 4.3%
Q1 201523 Apr
EPS$1.28
Miss 3.8%
Q4 201429 Jan
EPS$1.30
Beat 0.8%
Q3 201423 Oct
EPS$1.27
Beat 9.5%
Q2 201424 Jul
EPS$1.12
Beat 4.7%
Q1 201424 Apr
EPS$1.53
Beat 21.4%
Q4 201330 Jan
EPS$0.87
Beat 4.8%
Q3 201324 Oct
EPS$0.83
Beat 5.1%
Q2 201325 Jul
EPS$0.73
Beat 7.3%
Q1 201325 Apr
EPS$0.65
Beat 6.6%
Q4 201214 Feb
EPS$0.60
Beat 13.2%
Q3 201224 Oct
EPS$0.60
Beat 27.7%
Q2 201225 Jul
EPS$0.47
Beat 27.0%
Q1 201224 Apr
EPS$0.45
Beat 15.4%
Q4 20119 Feb
EPS$0.41
Beat 20.6%
Q3 201120 Oct
EPS$0.37
Beat 27.6%
Q2 201121 Jul
EPS$0.29
Beat 7.4%
Q1 201121 Apr
EPS$0.30
Beat 20.0%
Q4 201010 Feb
EPS$0.26
Beat 4.0%
Q3 201021 Oct
EPS$0.25
Beat 13.6%
Q2 201022 Jul
EPS$0.20
Beat 5.3%
Q1 201022 Apr
EPS$0.19
Beat 11.8%
Q4 200911 Feb
EPS$0.16
Beat 33.3%
Q3 200922 Oct
EPS$0.19
Beat 72.7%
Q2 200923 Jul
EPS$0.13
Beat 62.5%
Q1 200923 Apr
EPS$0.13
Beat 85.7%
Q4 200812 Feb
EPS$0.09
Beat 114.9%
Q3 200823 Oct
EPS$0.12
Beat 482.2%
Q2 200829 Jul
EPS$0.02
Beat 143.9%
Q1 200830 Apr
EPS$-0.03
Beat 72.7%
Q4 200714 Feb
EPS$-0.08
Beat 33.3%
Q3 200725 Oct
EPS$-0.14
Beat 22.2%
Q2 200725 Jul
EPS$-0.19
Beat 26.9%
Q1 20071 May
EPS$-0.23
Beat 14.8%
Q4 200615 Feb
EPS$-0.30
Miss 3.5%
Q3 20061 Nov
EPS$-0.25
Beat 7.4%
Q2 20068 Aug
EPS$-0.26
Miss 18.2%
Q1 200627 Apr
EPS$-0.22
Beat 12.0%
Q3 20056 Dec
EPS$-0.29
Miss 16.0%
Q1 20053 Jun
EPS$-0.29
Miss 11.5%
Q4 20044 Mar
EPS$-0.22
Beat 8.3%
Q3 20043 Dec
EPS$-0.17
Beat 32.0%
Q2 200424 Sept
EPS$-0.22
Beat 24.1%
Q1 20043 Jun
EPS$-0.17
Beat 37.0%
Q4 20035 Mar
EPS$-0.21
Beat 16.0%
Q3 200311 Dec
EPS$-0.25
Beat 0.0%
Q2 200331 Jul
EPS$-0.27
Q1 20036 Jun
EPS$-0.27
Beat 10.0%
Q4 20027 Mar
EPS$-0.29
Beat 6.5%
Q3 20026 Dec
EPS$-0.30
Beat 3.2%
Q2 200231 Jul
EPS$-0.29
Q1 20027 Jun
EPS$-0.23
Beat 25.8%
Q4 20018 Mar
EPS$-0.15
Beat 31.8%
Q3 20017 Dec
EPS$-0.11
Beat 21.4%
Q2 200131 Jul
EPS$-0.10
Q1 20017 Jun
EPS$-0.08
Beat 20.0%
Q4 20008 Mar
EPS$-0.05
Beat 68.8%
Q3 20007 Dec
EPS$-0.13
Miss 8.3%
Q2 200031 Jul
EPS$-0.08
Q1 20008 Jun
EPS$-0.10
Miss 42.9%
Q4 199928 Feb
EPS$-0.06
Beat 14.3%
Q3 199910 Dec
EPS$-0.11
Beat 8.3%
Q2 199931 Jul
EPS$-0.09
Q1 199910 Jun
EPS$0.14
Beat 7.7%
Q4 199811 Mar
EPS$-0.11
Miss 57.1%
Q3 19988 Oct
EPS$-0.08
Beat 0.0%
Q2 199831 Jul
EPS$-0.08
Q1 199828 May
EPS$-0.07
Beat 12.5%
Q4 199712 Mar
EPS$-0.08
Beat 0.0%
Q3 19979 Dec
EPS$0.03
Beat 116.6%
Q2 199731 Jul
EPS$-0.07
Q1 199716 Jun
EPS$-0.06
Beat 25.0%
Q4 199617 Mar
EPS$-0.04
Beat 42.9%
Q3 199630 Oct
EPS$-0.07
Beat 12.5%
Q2 199631 Jul
EPS$-0.06
Q1 199618 Jun
EPS$-0.04
Beat 42.9%
Q4 199531 Jan
EPS$-0.06
Q3 199531 Oct
EPS$-0.07

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

23 May 2011Stock Split
Ratio2:1
25 Aug 2008Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ALXN

Which members of Congress have traded ALXN?
2 members of Congress have disclosed 9 trades in ALXN (ALXN) under the STOCK Act. The most active traders are Gilbert Cisneros and Lois Frankel.
When was ALXN most recently disclosed by Congress?
The most recent ALXN disclosure was a sale by Gilbert Cisneros on 22 December 2020.
What is the total disclosed congressional trading volume for ALXN?
Members of Congress have disclosed approximately $32K in ALXN purchases and $123.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ALXN?
This ALXN page updates as soon as new STOCK Act disclosures are filed for ALXN. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.